Falcon Wealth Planning
Source: SEC Form 13F · as of Mar 2026Falcon Wealth Planning holds 11 biotech & pharma companies tracked by BioSniper, totaling $5.4M in value as of Mar 2026 (SEC Form 13F).
Companies held
11
Total value held
$5.4M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 1,324 | $1.2M |
| JNJJOHNSON & JOHNSON | 4,608 | $1.1M |
| ABBVAbbVie Inc. | 3,011 | $655K |
| MRKMerck & Co., Inc. | 4,426 | $533K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 1,528 | $413K |
| AMGNAMGEN INC | 864 | $304K |
| MAZEMaze Therapeutics, Inc. | 9,639 | $288K |
| BMYBRISTOL MYERS SQUIBB CO | 4,566 | $277K |
| PFEPFIZER INC | 7,658 | $215K |
| ABTABBOTT LABORATORIES | 2,080 | $214K |
| GNLXGENELUX Corp | 63,185 | $153K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.